SBE - Lloyds Banking Group QuantumScape leads premarket losers' pack
Oncternal Therapeutics (ONCT) -25% on increasing previously announced bought deal offer to $75.0M.GeoVax Labs (GOVX) -23%.Xenetic Biosciences (XBIO) -21%. on launching $6M registered direct offering priced at-the-market.Savara (SVRA) -19% on providing pipeline and business update.AquaBounty Technologies (AQB)-18% after proposes underwritten public offering of common stock.Francesca's Holdings (FRAN) -12%.ZW Data Action Technologies (CNET) -12%.J.Jill (JILL) -12% on Q3 earnings release.Genetic Technologies (GENE) -12%.Usio (USIO) -11%.Fisker (FSR) -4%.Obalon Therapeutics (OBLN) -9%.Recon Technology (RCON) -9%.Switchback Energy Acquisition (SBE) -2%.Cancer Genetics (CGIX) -8%.RAVE Restaurant Group (RAVE) -8%.Tuscan Holdings (THCB) -8%.Yunhong CTI (CTIB) -7%.QuantumScape (QS) -7%.Qiwi (QIWI) -7%.Intec Pharma (NTEC) -7%.Ciena (CIEN) -7% on Q4 earnings release.ASLAN Pharmaceuticals (ASLN) -7%.Lloyds Banking Group (LYG) -7%.Fangdd Network Group (DUO) -6%.Infinity Pharmaceuticals (INFI) -6%.Lexicon Pharmaceuticals (LXRX) -6%.
For further details see:
Lloyds Banking Group, QuantumScape leads premarket losers' pack